-
-
Overview
-
Please contact us at for specific academic pricing.
Background
Eribulin Mesylate (E7389 Mesylate), a synthetic analogue of halichondrin B in phase III clinical trials for breast cancer, binds to tubulin and microtubules.
-
- Properties
- Applications
-
Overview